Dividends Inside 
SPDR S&P Biotech ETF
XBI
$156.79 (- $0.07 - 0.04%)
Last updated: 2026-08-14 18:07 UTC
SPDR S&P Biotech ETF trades under ticker XBI on NYSE as an ETF. Use this page to review its market price, share price, dividends, and price history. The page also shows Health exposure. Identifiers: ISIN US78464A8707, CUSIP 78464A870.
Related researchXBI ETF priceXBI share priceXBI dividend historyXBI dividend yieldSPDR S&P Biotech ETF dividend historySPDR S&P Biotech ETF dividend yield78464A870SPDR S&P Biotech ETFSPDR S&P Biotech ETF share price
About the Company
SPDR S&P Biotech ETF is an exchange-traded fund designed to track an equal-weighted index of U.S. biotechnology stocks. The fund gives investors broad exposure to the biotechnology segment of the healthcare market, with holdings that typically include companies involved in drug discovery, genetic research, therapeutic development, diagnostics, and advanced life sciences tools. Its equal-weighted approach reduces concentration in the largest names and provides more balanced representation across smaller and mid-sized biotech companies. SPDR S&P Biotech ETF is used as a diversified vehicle for gaining exposure to a sector known for innovation, scientific research, and product development across human health and medical technology. Managed by State Street, the fund serves market participants looking for targeted access to the biotech industry through a single pooled portfolio.